Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

NCT05323617 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Operational

Conditions

Severe Aplastic Anemia (SAA)

Interventions

DRUG: Romiplostim
DRUG: Antithymocyte Globulin
DRUG: Cyclosporine A

Sponsor

Amgen